"10.1371_journal.pone.0100610","plos one","2014-07-21T00:00:00Z","Rachel A Gibson; Jon Robertson; Harshna Mistry; Stewart McCallum; Disala Fernando; Melody Wyres; Gil Yosipovitch","Academic Discovery Performance Unit, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom; Quantitative Sciences, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom; Clinical Pharmacology Science and Study Operations GlaxoSmithKline, Cambridge, Cambridgeshire, United Kingdom; Academic Discovery Performance Unit, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America; Clinical Unit, GlaxoSmithKline, Cambridge, Cambridgeshire, United Kingdom; Clinical Development, Stiefel, a GSK company, Research Triangle Park, North Carolina, United States of America; Department of Dermatology and Temple Itch Center, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: RG JR HM SM DF MW GY. Analyzed the data: JR. Wrote the paper: RG JR HM SM DF MW GY. Oversight of the clinical study: HM SM DF. Interim Review of Data: RG JR HM SM DF MW GY.","Rachel A. Gibson, Jon Robertson, Harshna Mistry, Stewart McCallum, Disala Fernando and Melody Wyres are all paid employees of GlaxoSmithKline. Gil Yosipovitch has previously worked as a paid consultant for GlaxoSmithKline/Stiefel and is in receipt of funding support for ongoing projects. This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.","2014","07","Rachel A Gibson","RAG",7,TRUE,7,NA,1,7,TRUE,FALSE,FALSE,0,NA,FALSE
